October 30, 2019
Dendreon Completes Enrollment of Phase 3 ProVent Clinical Trial Evaluating Sipuleucel-T in Men on Active Surveillance
Dendreon has completed enrollment of of 450 patients, in Phase 3 ProVent clinical trial testing Sipuleucel-T in men on active…